• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Sciences

    Seastar Medical Publishes Positive Real-World Data

    GLOBENEWSWIRE

    SeaStar to Present QUELIMMUNE Data in Pediatric AKI at Symposium

    GLOBENEWSWIRE

    SeaStar Study Projects Lower Pediatric AKI Costs, Higher Survival

    GLOBENEWSWIRE

    SeaStar Medical`s $4.4M Direct Offering Priced Under Nasdaq Rules

    GLOBENEWSWIRE

    Positive Results for SeaStar`s QUELIMMUNE in Pediatric AKI

    GLOBENEWSWIRE

    SeaStar Medical Announces $4 Million Direct Offering Under

    GLOBENEWSWIRE

    SeaStar Hits Enrollment Goal for AKI Trial of SCD Therapy

    GLOBENEWSWIRE

    FDA Grants SeaStar 2 Breakthrough Tags for SCD Therapy

    GLOBENEWSWIRE

    SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

    GLOBENEWSWIRE

    SeaStar Medical Ships Quelimmune To Fourth Hospital Customer

    GLOBENEWSWIRE

    SeaStar Activates 14th Hospital for Adult AKI Pivotal Trial

    GLOBENEWSWIRE

    SeaStar Projects Multibillion-Dollar Market Potential for Device

    GLOBENEWSWIRE

    SeaStar Medical Activates Hospital for Adult AKI Pivotal Trial

    GLOBENEWSWIRE

    SeaStar Medical Ships 100th QUELIMMUNE Device to 3rd Hospital

    GLOBENEWSWIRE

    FDA Grants Breakthrough Device Designation to SeaStar Medical

    GLOBENEWSWIRE

    SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

    GLOBENEWSWIRE

    Economic Analysis Shows Cost Reduction with QUELIMMUNE Device

    GLOBENEWSWIRE

    SeaStar Medical To Distribute QUELIMMUNE To Hospitals Directly

    GLOBENEWSWIRE

    SeaStar to Present at the 2024 Maxim Healthcare Virtual Summit

    GLOBENEWSWIRE

    SeaStar Expands NEUTRALIZE-AKI Trial With Military Facilities

    GLOBENEWSWIRE

    SeaStar Medical Reports Enrollment Momentum In AKI Trial

    GLOBENEWSWIRE

    SeaStar Medical Eliminates All Long-Term Debt

    GLOBENEWSWIRE

    Paper On SeaStar Cytopheretic Device Enabling Transplants

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.